MRK•benzinga•
What's Going On With Summit Therapeutics Stock On Friday?
Summary
Summit Therapeutics' partner Akeso received FDA approval for penpulimab-kcqx in NPC, while ivonescimab showed strong data in lung cancer trials.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 25, 2025 by benzinga